The Europe Burn Ointment Market is expected to witness market growth of 5.3% CAGR during the forecast period (2020-2026).
Increasing awareness among people about the obtainability of various treatment methods is one of the major factor that contribute to the growth of the burn ointment market. With time, consumers spending on more for better care in case of blaze accidents due to favorable reimbursements from medicare programs. Patients are concentrating on buying advanced products for the treatment bounds caused by burning. Numerous burn ointments are available in the market such as topical antibiotics, silver, and iodine-based.
To prevent the risk of hospital-acquired infection (HAI) in patients, companies involved in manufacturing healthcare products including burn injury treatment are bringing improved silver sulfadiazine (SSD) creams that minimize complications and other health risks. Healthcare professionals are in the hunt for the expertise of scientists and researchers to do an experiment on silver-containing dressings with honey, since honey offers antiseptic effects that cause faster healing of burn injuries. Healthcare companies are focused to increase their research on dressings infused with sodium hypochlorite that may give faster healing results if compared to SSD dressings.
Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
Scope of the Study
Market Segments covered in the Report:
By Depth of Burn
By Product
By End Use
By Country
Companies Profiled
Unique Offerings from the Publisher
Increasing awareness among people about the obtainability of various treatment methods is one of the major factor that contribute to the growth of the burn ointment market. With time, consumers spending on more for better care in case of blaze accidents due to favorable reimbursements from medicare programs. Patients are concentrating on buying advanced products for the treatment bounds caused by burning. Numerous burn ointments are available in the market such as topical antibiotics, silver, and iodine-based.
To prevent the risk of hospital-acquired infection (HAI) in patients, companies involved in manufacturing healthcare products including burn injury treatment are bringing improved silver sulfadiazine (SSD) creams that minimize complications and other health risks. Healthcare professionals are in the hunt for the expertise of scientists and researchers to do an experiment on silver-containing dressings with honey, since honey offers antiseptic effects that cause faster healing of burn injuries. Healthcare companies are focused to increase their research on dressings infused with sodium hypochlorite that may give faster healing results if compared to SSD dressings.
Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
Scope of the Study
Market Segments covered in the Report:
By Depth of Burn
- Minor Burns
- Partial Thickness Burns
- Full Thickness Burns
By Product
- Topical Antibiotics
- Silver
- Iodine
- Other Products
By End Use
- Clinics
- Hospitals
- Other End Use
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Johnson and Johnson
- ConvaTec Group PLC
- Smith & Nephew PLC
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Perrigo Company PLC
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Dr. Morepen Limited
- Mankind Pharma Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Burn Ointment Market by Depth of Burn
Chapter 4. Europe Burn Ointment Market by Product
Chapter 5. Europe Burn Ointment Market by End Use
Chapter 6. Europe Burn Ointment Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Johnson and Johnson
- ConvaTec Group PLC
- Smith & Nephew PLC
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Perrigo Company PLC
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Dr. Morepen Limited
- Mankind Pharma Ltd.
Methodology
LOADING...
